Bank of America’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
987,495
+38,686
+4% +$43.7K ﹤0.01% 4391
2025
Q1
$1.39M Sell
948,809
-214,934
-18% -$314K ﹤0.01% 4167
2024
Q4
$2.48M Buy
1,163,743
+579,818
+99% +$1.24M ﹤0.01% 3590
2024
Q3
$1.63M Buy
583,925
+151,222
+35% +$423K ﹤0.01% 3980
2024
Q2
$1.01M Buy
432,703
+28,321
+7% +$66K ﹤0.01% 4173
2024
Q1
$1.81M Buy
404,382
+73,494
+22% +$329K ﹤0.01% 3796
2023
Q4
$1.06M Sell
330,888
-505,579
-60% -$1.62M ﹤0.01% 4103
2023
Q3
$2.65M Buy
836,467
+120,998
+17% +$384K ﹤0.01% 3348
2023
Q2
$3.56M Sell
715,469
-316,195
-31% -$1.57M ﹤0.01% 3128
2023
Q1
$5.1M Buy
1,031,664
+167,186
+19% +$826K ﹤0.01% 3012
2022
Q4
$5.44M Buy
864,478
+500,817
+138% +$3.15M ﹤0.01% 2836
2022
Q3
$3.93M Buy
363,661
+95,669
+36% +$1.03M ﹤0.01% 3039
2022
Q2
$3.06M Sell
267,992
-311,934
-54% -$3.56M ﹤0.01% 3374
2022
Q1
$5.28M Buy
579,926
+310,292
+115% +$2.83M ﹤0.01% 3084
2021
Q4
$4.02M Buy
269,634
+211,768
+366% +$3.16M ﹤0.01% 3316
2021
Q3
$1.49M Sell
57,866
-105,235
-65% -$2.7M ﹤0.01% 4028
2021
Q2
$4.25M Buy
163,101
+104,178
+177% +$2.72M ﹤0.01% 3164
2021
Q1
$2.08M Sell
58,923
-280,345
-83% -$9.9M ﹤0.01% 3712
2020
Q4
$8.56M Buy
339,268
+296,300
+690% +$7.48M ﹤0.01% 2281
2020
Q3
$1.62M Sell
42,968
-5,505
-11% -$208K ﹤0.01% 3372
2020
Q2
$2.08M Buy
48,473
+19,370
+67% +$829K ﹤0.01% 3203
2020
Q1
$565K Buy
29,103
+601
+2% +$11.7K ﹤0.01% 3922
2019
Q4
$740K Sell
28,502
-9,016
-24% -$234K ﹤0.01% 4031
2019
Q3
$1.02M Sell
37,518
-33,470
-47% -$912K ﹤0.01% 3852
2019
Q2
$1.91M Sell
70,988
-23,954
-25% -$643K ﹤0.01% 3491
2019
Q1
$2.75M Buy
94,942
+74,509
+365% +$2.15M ﹤0.01% 3218
2018
Q4
$551K Buy
+20,433
New +$551K ﹤0.01% 4211